Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
3.400
+0.040 (1.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Scinai Immunotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 1.03 | 4.87 | 14.08 | 17.37 | 9.42 | 72.47 | Upgrade
|
| Cash & Short-Term Investments | 1.03 | 4.87 | 14.08 | 17.37 | 9.42 | 72.47 | Upgrade
|
| Cash Growth | -83.78% | -65.40% | -18.99% | 84.42% | -87.00% | -4.50% | Upgrade
|
| Other Receivables | - | 0.37 | 0.11 | 0.1 | 0.23 | 0.35 | Upgrade
|
| Receivables | 0.12 | 0.37 | 0.11 | 0.1 | 0.23 | 0.35 | Upgrade
|
| Prepaid Expenses | 0.33 | 0.07 | 0.05 | 0.23 | 0.98 | 0.31 | Upgrade
|
| Restricted Cash | 0.14 | 0.14 | 0.14 | 0.14 | - | - | Upgrade
|
| Total Current Assets | 1.62 | 5.45 | 14.37 | 17.84 | 10.63 | 73.12 | Upgrade
|
| Property, Plant & Equipment | 10.64 | 12.03 | 12.7 | 14.19 | 45.81 | 42.12 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0.47 | 0.51 | Upgrade
|
| Total Assets | 12.26 | 17.47 | 27.07 | 32.04 | 56.91 | 115.75 | Upgrade
|
| Accounts Payable | 0.43 | 0.54 | 0.72 | 1 | 1.87 | 17.06 | Upgrade
|
| Accrued Expenses | 0.6 | 0.85 | 1.24 | 1.07 | 1.25 | 1.2 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 60.42 | - | Upgrade
|
| Current Portion of Leases | 0.36 | 0.4 | 0.38 | 0.38 | 0.65 | 0.69 | Upgrade
|
| Total Current Liabilities | 1.39 | 1.78 | 2.34 | 2.44 | 64.19 | 18.96 | Upgrade
|
| Long-Term Debt | 0.28 | 19.37 | 20.08 | 27.16 | - | 123.78 | Upgrade
|
| Long-Term Leases | 0.58 | 0.8 | 1.08 | 1.45 | 6.09 | 6.81 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | - | 14.81 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0.1 | 5.33 | - | 1.14 | 16.35 | Upgrade
|
| Total Liabilities | 2.26 | 22.04 | 28.83 | 31.05 | 71.51 | 180.8 | Upgrade
|
| Additional Paid-In Capital | 121.43 | 119.51 | 116.08 | 113.08 | 310.2 | 255.29 | Upgrade
|
| Retained Earnings | -115.31 | -122.34 | -115.84 | -110.04 | -324.79 | -320.34 | Upgrade
|
| Comprehensive Income & Other | -1.74 | -1.74 | -2.01 | -2.06 | - | - | Upgrade
|
| Shareholders' Equity | 10 | -4.57 | -1.76 | 0.98 | -14.6 | -65.05 | Upgrade
|
| Total Liabilities & Equity | 12.26 | 17.47 | 27.07 | 32.04 | 56.91 | 115.75 | Upgrade
|
| Total Debt | 1.23 | 20.56 | 21.54 | 28.99 | 67.16 | 131.28 | Upgrade
|
| Net Cash (Debt) | -0.2 | -15.69 | -7.47 | -11.61 | -57.74 | -58.82 | Upgrade
|
| Net Cash Per Share | -0.34 | -40.17 | -39.61 | -82.26 | -521.07 | -720.23 | Upgrade
|
| Filing Date Shares Outstanding | 0.85 | 0.46 | 0.33 | 0.19 | 0.12 | 0.1 | Upgrade
|
| Total Common Shares Outstanding | 0.85 | 0.46 | 0.33 | 0.19 | 0.12 | 0.1 | Upgrade
|
| Working Capital | 0.23 | 3.67 | 12.03 | 15.4 | -53.56 | 54.16 | Upgrade
|
| Book Value Per Share | 11.73 | -9.84 | -5.36 | 5.22 | -126.57 | -646.73 | Upgrade
|
| Tangible Book Value | 10 | -4.57 | -1.76 | 0.98 | -14.6 | -65.05 | Upgrade
|
| Tangible Book Value Per Share | 11.73 | -9.84 | -5.36 | 5.22 | -126.57 | -646.73 | Upgrade
|
| Machinery | - | 2.46 | 1.92 | 1.23 | 3.65 | 4.05 | Upgrade
|
| Construction In Progress | - | 7.45 | 7.83 | 8.86 | - | - | Upgrade
|
| Leasehold Improvements | - | 3.72 | 3.92 | 4.43 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.